Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Technology
History
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts114/v4/8a/61/9e/8a619eda-4370-c5a1-6a8d-8ed30aac4c4f/mza_12824525197888336905.jpg/600x600bb.jpg
Checkpoint NOW
Afreen Shariff
32 episodes
2 days ago
All you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.
Show more...
Medicine
Health & Fitness
RSS
All content for Checkpoint NOW is the property of Afreen Shariff and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
All you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.
Show more...
Medicine
Health & Fitness
https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded/7711112/7711112-1605830906092-4f856047119d3.jpg
Episode 31: Journal Club: To re-challenge or not in refractory pneumonitis
Checkpoint NOW
37 minutes 39 seconds
5 months ago
Episode 31: Journal Club: To re-challenge or not in refractory pneumonitis

Host Dr. Afreen Shariff is joined by guest host Dr. Pankti Reid, Rheumatologist, University of Chicago where they discuss the topic "To re-challenge or not in refractory pneumonitis" with expert Pulmonologist Dr. Kevin Ho (The Ohio State University) and Medical Oncologist Dr. Aliyah Pabani (Johns Hopkins Medicine) who discuss some key articles.


Articles: https://pmc.ncbi.nlm.nih.gov/articles/PMC7797270/Balaji, et al, J Immunother Cancer. 2021

https://pubmed.ncbi.nlm.nih.gov/33568350/ Beattie, et al, J Immunother Cancer. 2021

Checkpoint NOW
All you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.